Aliophen
Aliophen
Patent No. 102017000096298 entitled “Method for the production of a polyphenolic composition starting from barley malt” filed and registered jointly with the National Research Council”


About

ALIOPHARM® is a company specializing in research and experimental development in the field of natural sciences, with the aim of offering the market high-value natural raw materials, the subject of scientific innovation.

Aliopharm operates in three specific divisions:

  • FUNCTIONAL FOODS AND NUTRACEUTICALS DIVISION
  • COSMETICS DIVISION
  • ANIMAL FEED AND VETERINARY NUTRITION DIVISION
Among the main results of our scientific activities, in collaboration with the National Research Council (CNR), we have developed ALIOPHEN®, a natural extract from selected malts and hops, rich in polyphenols at their original concentrations.

Scientific Collaborations

ALIOPHARM® actively collaborates with academic institutions, universities, and public research centers on experimental projects in the nutraceutical, cosmetic, and veterinary sectors.

These collaborations allow us to evaluate the efficacy and safety of our raw materials through rigorous scientific protocols, contributing validated and publishable results to the independent literature.

Aliopharm
 

What makes us so unique

ALIOPHARM®: Where Science and Nature Meet

We believe in a future where nature and science collaborate to select and offer natural and sustainable ingredients. ALIOPHEN® represents our contribution, combining Italian tradition with scientific innovation.

Our Mission

Combining tradition and innovation to develop advanced solutions based on natural ingredients such as barley malt and hops.

ALIOPHEN®: Patented Italian Excellence

ALIOPHEN® is an extract produced with a patented process, developed in collaboration with the CNR (National Research Council), which guarantees science and quality.

Why Choose ALIOPHEN®

  • Uniqueness: Patented process and product designed by experts for innovative formulations
  • Scientific Innovation: Developed and validated through rigorous studies, obtained through aqueous extraction, without the use of solvents
  • Natural Ingredients: Extracted from selected malts and hops, symbols of Made in Italy quality and tradition, rich in polyphenols at original concentrations
  • Versatility: Adapts to any formulation and dissolves easily in any type of solution.

Continuing Research

Thanks to the work of internationally renowned scientists, ALIOPHARM® continues to invest in studies on the potential of malt and hop extracts ALIOPHEN®.

ALIOPHEN® represents a concrete commitment that combines Italian excellence, sustainability, and scientific research to offer natural solutions Made in Italy.

Aliophen ®

Aliopharm

ALIOPHEN® is a plant extract obtained by mixing water, barley malts, and selected hops, without the addition of yeast, to prevent fermentation and alcohol production.
Its extraction occurs through an exclusive process in water, without the use of solvents.

ALIOPHEN® is rich in natural polyphenols at their original concentrations and preserves the integrity of the bioactive compounds.
It is completely soluble, making it highly versatile for various types of formulations.

Developed entirely in Italy, it is the result of research conducted in collaboration with the CNR-ISA of Avellino, and was born from the analysis of the nutritional and compositional properties of beers, with particular attention to the polyphenolic profile of malts and hops, subsequently selected and used in the production of Aliophen.

Thanks to its application flexibility, ALIOPHEN ® is now available in three dedicated lines, each optimized for the specific needs of the sector:

  • ALIOPHEN FOOD
    Raw material for food products, usable in pure form or as a component of dietary supplements and functional foods
  • ALIOPHEN COSMETICS
    Raw material intended for use as an active ingredient in cosmetic formulations
  • ALIOPHEN VET
    Raw material ingredient for the formulation of preparations intended for animal nutrition and feed, also usable in pure form or as a component of supplements.

Aliopharm

Patents

Italian patent no. 102017000096298 entitled "Method for the production of a polyphenolic composition starting from barley malt" was filed and registered and later extended to Europe, the USA, CHINA and Canada.

The Italian patent application no. 102024000016369 has been filed entitled "New Polyphenolic Composition"

Aliopharm

Scientific Publications

The beneficial properties of the product resulting from the studies conducted have not been endorsed by the European Food Safety Authority (EFSA).
The beneficial effects of Aliophen ® on health have not been expressly recognized and authorized by EFSA.

Antioxidant and Chemopreventive Effect of Aliophen® Formulation Based on Malts and Hops

by Idolo Tedesco 1 ,Carmela Spagnuolo 1, ,Stefania Bilotto 1, Angelo A. Izzo 2, Francesca Borrelli,Daniela Rigano 2,Maria Russo 1,Fabrizio Tarricone 3 and Gian Luigi Russo 1.
  1. National Research Council, Institute of Food Sciences, 83100 Avellino, Italy
  2. Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy
  3. ALIOPHARM S.r.l., 20124 Milan, Italy
Antioxidants 2021, 10(1), 29;

Team ALIOPHARM ®

Fabrizio Tarricone

Fabrizio Tarricone

Sole Director
Antonio Frungillo

Antonio Frungillo

Sales and Management Consultant
Veronica Vignati

Veronica Vignati

Sales Junior Scientific
Lavinia Mariani

Lavinia Mariani

Sales Junior Scientific
Marzia Pellizzato

Marzia Pellizzato

Technical, Scientific and Regulatory Consultant
Alessandro Colletti

Alessandro Colletti

Technical, Scientific Consultant
Ruggero Amato

Ruggero Amato

Veterinary Technical and Scientific Consultant
Eva Adabbo

Eva Adabbo

Quality Manager
Giuseppe Cerone

Giuseppe Cerone

Digital Branding & Talent Acquisition Manager
Francesca Giovine

Francesca Giovine

Office Assistant

Scientific Collaborations

Institute of Food Sciences of the National Research Council of Avellino (CNR-ISA) and Aliopharm S.r.l.

A scientific collaboration agreement is in place between CNR-ISA and the company ALIOPHARM, coordinated by Dr. Gian Luigi Russo and Dr. Carmela Spagnuolo

Gian Luigi Russo
Dott.

Gian Luigi Russo

Carmela Spagnuolo
Dott.ssa

Carmela Spagnuolo


Department of Pharmaceutical Science and Technology of Turin and Aliopharm

A scientific collaboration coordinated by Prof. Giancarlo Cravotto exists between the Department of Pharmaceutical Science and Technology of the University of Turin and Aliopharm.
Giancarlo Cravotto
Prof.

Giancarlo Cravotto

 
Aliophen
 

Contacts

ALIOPHARM S.r.l.
with a single partner
Via Napo Torriani, 31
20124 Milano (MI) - Italy
VAT: 10359920963
Phone: (+39) 02.70017411
Email: info@aliopharm.com